Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

B. V. Jensen; K-L G Spindler; I. J. Christensen; JV Schou; D. L. Nielsen; A Jakobsen; E. Hogdall; P Pfeiffer; M. K. Yilmaz; J Johansen

doi:10.1093/annonc/mdw363.43

Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

B. V. Jensen, K-L G Spindler, I. J. Christensen, JV Schou, D. L. Nielsen, A Jakobsen, E. Hogdall, P Pfeiffer, M. K. Yilmaz, J Johansen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	95P
Journal	Annals of Oncology
Volume	27
Issue number	Suppl. 6
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdw363.43
Publication status	Published - 2016
Event	41st ESMO Congress: From disease treatment to patient care - København, Denmark Duration: 7 Oct 2016 → 11 Oct 2016 Conference number: 41 http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress

Conference

Conference	41st ESMO Congress
Number	41
Country/Territory	Denmark
City	København
Period	07/10/2016 → 11/10/2016
Internet address	http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress

Bibliographical note

ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Christensen, T. D. Palshof, J. A. Larsen, F. O. Hogdall, E. Poulsen, T. S. Jensen, B. V. Pfeiffer, P. Yilmaz, M. K. Christensen, I. J. Nielsen, D. L. Danish Cancer Society The Danish Cancer Society 0 Oxford univ press Oxford 1569-8041 6

Keywords

Oncology

Access to Document

10.1093/annonc/mdw363.43

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Jensen, B. V., Spindler, K-L. G., Christensen, I. J., Schou, JV., Nielsen, D. L., Jakobsen, A., Hogdall, E., Pfeiffer, P., Yilmaz, M. K., & Johansen, J. (2016). Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan. Annals of Oncology, 27(Suppl. 6), Article 95P. https://doi.org/10.1093/annonc/mdw363.43

@article{f79167a281204b869ac49a37031a1ae4,

title = "Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan",

keywords = "Oncology",

author = "Jensen, {B. V.} and Spindler, {K-L G} and Christensen, {I. J.} and JV Schou and Nielsen, {D. L.} and A Jakobsen and E. Hogdall and P Pfeiffer and Yilmaz, {M. K.} and J Johansen",

note = "ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Christensen, T. D. Palshof, J. A. Larsen, F. O. Hogdall, E. Poulsen, T. S. Jensen, B. V. Pfeiffer, P. Yilmaz, M. K. Christensen, I. J. Nielsen, D. L. Danish Cancer Society The Danish Cancer Society 0 Oxford univ press Oxford 1569-8041 6; 41st ESMO Congress ; Conference date: 07-10-2016 Through 11-10-2016",

year = "2016",

doi = "10.1093/annonc/mdw363.43",

language = "English",

volume = "27",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 6",

url = "http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress",

}

TY - ABST

T1 - Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

AU - Jensen, B. V.

AU - Spindler, K-L G

AU - Christensen, I. J.

AU - Schou, JV

AU - Nielsen, D. L.

AU - Jakobsen, A

AU - Hogdall, E.

AU - Pfeiffer, P

AU - Yilmaz, M. K.

AU - Johansen, J

N1 - Conference code: 41

PY - 2016

Y1 - 2016

KW - Oncology

U2 - 10.1093/annonc/mdw363.43

DO - 10.1093/annonc/mdw363.43

M3 - Conference abstract in journal

SN - 0923-7534

VL - 27

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 6

M1 - 95P

T2 - 41st ESMO Congress

Y2 - 7 October 2016 through 11 October 2016

ER -